|
LEMD3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.790230E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.986200E-01 |
| Normal-vs-Stage2 |
3.548000E-01 |
| Normal-vs-Stage3 |
3.646300E-04 |
| Normal-vs-Stage4 |
1.81054999999208E-05 |
| Stage1-vs-Stage2 |
7.287400E-01 |
| Stage1-vs-Stage3 |
5.958200E-04 |
| Stage1-vs-Stage4 |
6.46930000000046E-05 |
| Stage2-vs-Stage3 |
1.641420E-01 |
| Stage2-vs-Stage4 |
6.013900E-02 |
| Stage3-vs-Stage4 |
3.945400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.144700E-03 |
| Normal-vs-AfricanAmerican |
2.666000E-02 |
| Normal-vs-Asian |
5.842200E-01 |
| Caucasian-vs-AfricanAmerican |
6.810800E-01 |
| Caucasian-vs-Asian |
7.408800E-01 |
| AfricanAmerican-vs-Asian |
6.097200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.704200E-03 |
| Normal-vs-Female |
5.534000E-02 |
| Male-vs-Female |
4.142600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.675620E-02 |
| Normal-vs-Age(41-60Yrs) |
9.010400E-02 |
| Normal-vs-Age(61-80Yrs) |
5.480800E-03 |
| Normal-vs-Age(81-100Yrs) |
2.529800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.366400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.140200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.873400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.403980E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.727600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.521000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.218200E-01 |
| Normal-vs-Grade 2 |
6.463400E-01 |
| Normal-vs-Grade 3 |
6.08559999999425E-05 |
| Normal-vs-Grade 4 |
2.62589999744378E-08 |
| Grade 1-vs-Grade 2 |
3.314000E-01 |
| Grade 1-vs-Grade 3 |
1.577010E-03 |
| Grade 1-vs-Grade 4 |
3.71089999999796E-05 |
| Grade 2-vs-Grade 3 |
4.02910000000256E-05 |
| Grade 2-vs-Grade 4 |
3.87770004994792E-09 |
| Grade 3-vs-Grade 4 |
1.741510E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.973200E-01 |
| Normal-vs-ccB subtype |
2.400500E-03 |
| ccA subtype-vs-ccB subtype |
4.648200E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.480200E-02 |
| Normal-vs-N1 |
8.255700E-03 |
| N0-vs-N1 |
1.954030E-01 |
|
|
